NEWS CENTER

Position:

Group Announcement

Media reports

Group News

Shijiazhuang Fourth Pharmaceutical Launches the “2021 Quality Month” Campaign

Category:

Group Announcement

Time：2021-09-06

September 2021 was National Quality Month, with the theme “Deeply Implement Quality Improvement Initiatives and Vigorously Promote the Building of a Country Strong in Quality.” To strengthen quality-based management, comprehensively enhance quality awareness among all employees, foster a strong corporate culture that emphasizes quality, and deepen quality culture development, we will drive high-quality enterprise development.

Shijiazhuang Fourth Pharmaceutical Launches the “2021 Quality Month” Campaign

September 2021 was designated as National Quality Month, with the theme “Deeply Implement Quality Improvement Initiatives and Vigorously Promote the Building of a Country Strong in Quality.” To strengthen quality-based management, comprehensively enhance quality awareness among all employees, foster a strong corporate culture that places great emphasis on quality, and deepen quality culture development, thereby driving high-quality enterprise growth, Shijiazhuang Fourth Pharmaceutical Group recently launched a two-month “2021 Quality Month” campaign tailored to the company’s specific circumstances.

“Taking ‘Quality Month’ as an opportunity, we will further foster a positive environment in which all employees care about and value quality by enhancing our quality culture. We’ll also strengthen quality process control to deliver high-quality products, thus laying a solid foundation for a successful start to the 14th Five-Year Plan,” said Mr. Yu, Director of the Group’s Quality and Technology Center. The company has established a leading group and is carrying out various types of activities to ensure that “Quality Month” is implemented effectively, steadily, and efficiently.

It is understood that during “Quality Month,” Shijiazhuang No.4 Pharmaceutical Group will organize a variety of activities, including a quality-themed essay contest with prizes, the initiative “I’ll Contribute a Suggestion for Quality,” a quality speech competition, a quality knowledge quiz, a job skills competition, and an on-site management compliance assessment. These activities aim to promote and implement the principle “Quality starts with me; quality begins from the heart,” showcase the company’s achievements in quality development, disseminate the concept of high-quality development, and highlight Shiji Pharmaceutical’s new quality initiatives.

During “Quality Month,” we will focus on a variety of activities centered around quality, including rationalization proposals related to quality, on-site GMP compliance assessments, and skill competitions for key positions. The on-site compliance assessment will place particular emphasis on the “four checks”: checking quality awareness, assessing quality levels, verifying operational execution, and examining site management. These assessments will combine specialized and comprehensive inspections against relevant regulations and standards, thoroughly examining the implementation of GMP management at critical points in production—such as manufacturing workshops, inspection areas, and warehouses—and rewarding excellence while penalizing shortcomings. At the same time, we will organize targeted skill competitions for key production positions to enhance employees’ operational proficiency and improve the supervision and inspection capabilities of QA personnel.

Director Yu from the Group’s Quality and Technology Center said, “After the ‘Quality Month’ activities conclude, the leading group will conduct a comprehensive summary of the campaign. We’ll promptly promote effective work practices and management experiences, and promptly address and correct any existing problems, thereby achieving the goal of quality improvement that ‘Quality Month’ was designed to achieve.”

Keywords:

First Public Notice of the Environmental Impact Assessment for the Green Development Project of Active Pharmaceutical Ingredients by Shisi Pharmaceutical Group Hebei Guolong Pharmaceutical Co., Ltd.

Shisi Pharmaceutical Group’s Guangxiang Pharmaceutical and Guolong Pharmaceutical have both been included in Hebei Province’s list of “Specialized, Fine, and New” SMEs.

First Public Notice of the Environmental Impact Assessment for the Green Development Project of Active Pharmaceutical Ingredients by Shisi Pharmaceutical Group Hebei Guolong Pharmaceutical Co., Ltd.

Shisi Pharmaceutical Group’s Guangxiang Pharmaceutical and Guolong Pharmaceutical have both been included in Hebei Province’s list of “Specialized, Fine, and New” SMEs.